EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer - Sobrero, A F; Maurel, J; Fehrenbacher, L (J Clin Oncol, 2008)